Literature DB >> 14563016

Islet autoantibodies in cord blood from patients who developed type 1 diabetes mellitus at 15-30 years of age.

A Maria Elfving1, Bengt A Lindberg, Lennarth Nyström, Göran Sundkvist, Ake Lernmark, Sten-A Ivarsson.   

Abstract

Islet cell autoantibodies are early markers for type 1 diabetes. The aim of this study was to determine whether islet autoantibodies were present at birth in young adults who developed type 1 diabetes at 15-30 years of age. Cord blood sera from 30 patients who developed type 1 diabetes between 15 and 25 years of age and sera from 320 randomly selected control children were tested for islet cell antibodies (ICA) by indirect immunofluorescence and autoantibodies against the 65 kD isoform of glutamic acid decarboxylase (GADA), islet cell antigen-2 (IA-2A) and insulin (IAA) by radiobinding assays. The young adults who developed type 1 diabetes did not differ from controls in the cord blood prevalence of any of the four islet autoantibodies. This is in contrast to our previous findings that children who developed type 1 diabetes below 15 years of age had an increased prevalence of cord blood islet autoantibodies. Our present data suggest that, in contrast to children, pre- and perinatal risk factors are less likely to be involved in the development of type 1 diabetes in young adults.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14563016     DOI: 10.1080/0891693031000141040

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  2 in total

1.  Autoimmunity against INS-IGF2 protein expressed in human pancreatic islets.

Authors:  Norio Kanatsuna; Jalal Taneera; Fariba Vaziri-Sani; Nils Wierup; Helena Elding Larsson; Ahmed Delli; Hanna Skärstrand; Alexander Balhuizen; Hedvig Bennet; Donald F Steiner; Carina Törn; Malin Fex; Åke Lernmark
Journal:  J Biol Chem       Date:  2013-08-09       Impact factor: 5.157

2.  Maternal enterovirus infection during pregnancy as a risk factor in offspring diagnosed with type 1 diabetes between 15 and 30 years of age.

Authors:  Maria Elfving; Johan Svensson; Sami Oikarinen; Björn Jonsson; Per Olofsson; Göran Sundkvist; Bengt Lindberg; Ake Lernmark; Heikki Hyöty; Sten-Anders Ivarsson
Journal:  Exp Diabetes Res       Date:  2008
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.